Back to Search
IRENE GHOBRIAL, M.D.
M.D.
Medical Oncology Physician
NPI: 1306871637IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
226664(MA)
Education
OTHER
Class of 1995
Research & Publications (20)
Novel therapeutic agents in Waldenström's macroglobulinemia.
PMID 19362982·Clin Lymphoma Myeloma·2009
6-review
Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia.
PMID 16611306·Br J Haematol·2006
4-observational
Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.
PMID 16186599·J Clin Oncol·2005
8-other
Proteomic analysis of mantle-cell lymphoma by protein microarray.
PMID 15650054·Blood·2005
4-observational
Clinical outcome of patients with subcutaneous panniculitis-like T-cell lymphoma.
PMID 16019507·Leuk Lymphoma·2005
8-other
Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?
PMID 15665775·Transplantation·2005
8-other
Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era.
PMID 15621801·Leuk Lymphoma·2005
3-trial
Fatal coronary artery disease after unrelated donor bone marrow transplantation.
PMID 15008613·Mayo Clin Proc·2004
5-case
High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosis.
PMID 15160344·Cancer·2004
5-case
Radioimmunotherapy: a new treatment modality for B-cell non-Hodgkin's lymphoma.
PMID 15209190·Oncology (Williston Park)·2004
6-review
Initial immunoglobulin M 'flare' after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an Eastern Cooperative Oncology Group Study.
PMID 15493038·Cancer·2004
3-trial
Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
PMID 15008605·Mayo Clin Proc·2004
8-other
Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of response.
PMID 15551276·Am J Hematol·2004
5-case
Therapeutic options in patients with lymphoma and severe liver dysfunction.
PMID 14959910·Mayo Clin Proc·2004
8-other
Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma.
PMID 12953131·Bone Marrow Transplant·2003
8-other
Inhibitors of the ras oncogene as therapeutic targets.
PMID 12512383·Hematol Oncol Clin North Am·2002
6-review
Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180.
PMID 19506160·J Clin Oncol·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- DANA FARBER CANCER INSTITUTE, 44 BINNEY STREET
BOSTON, MA 02215 - Phone
- (617) 632-4198
Quick Facts
- NPI
- 1306871637
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile